E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia

Eur J Surg Oncol. 2004 Dec;30(10):1084-92. doi: 10.1016/j.ejso.2004.07.022.

Abstract

Aims: Total gastrectomy for gastric cardia tumours harbours a high risk of proximal resection line (PRL) involvement. The adhesion markers CD44v6 and E-cadherin were evaluated as predictive factors for PRL involvement independent of tumour stage.

Methods: Forty-nine gastrectomy specimens for gastric cardia carcinoma (type II) were evaluated for stage, resection margins, and CD44v6 and E-cadherin immunohistochemistry.

Results: PRL involvement was microscopically recognized in 49% of specimens. CD44v6 expression was found in 84% of intestinal tumours, and in 56% of diffuse/mixed tumours (p=0.045). In the group of resections performed with curative intent, the proximal extension of the resection (margin) was significantly shorter in E-cadherin negative tumours than in E-cadherin positive tumours (p=0.029). Histological type and stage of the tumour, lymph node metastases, and absence of E-cadherin expression, but not the presence of CD44v6 correlated with PRL involvement. Only the absence of E-cadherin expression appeared to be a significant predictor of PRL involvement, independent of tumour stage. Survival for patients with PRL involvement was shorter than that for patients after R0 resection (p=0.07). Stage was the only independent prognostic factor emerging from multivariate survival analysis (p=0.002).

Conclusions: When curative resection is intended in type II cardiac cancer patients, an oesophageal resection and gastric tube reconstruction should be considered, especially for a tumour without E-cadherin expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / surgery
  • Adult
  • Aged
  • Biomarkers, Tumor / analysis*
  • Cadherins / analysis*
  • Cardia / pathology*
  • Cardia / surgery
  • Cell Adhesion
  • Female
  • Forecasting
  • Gastrectomy*
  • Glycoproteins / analysis
  • Humans
  • Hyaluronan Receptors / analysis
  • Immunohistochemistry
  • Lymphatic Metastasis / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / surgery
  • Survival Analysis
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • CD44v6 antigen
  • Cadherins
  • Glycoproteins
  • Hyaluronan Receptors